CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,313 |
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −2,043 | $123.62 | $253K | 2,270 |
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,663 | $125.16 | $208K | 607 |
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −607 | $126.19 | $77K | 0 |
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,165 | 0 | ||
| 2026-10-21 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 0 | ||
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −476 | $121.14 | $58K | 139,314 |
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −2,072 | $122.62 | $254K | 137,242 |
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −2,604 | $123.29 | $321K | 134,638 |
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −920 | $124.37 | $114K | 133,718 |
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −597 | $125.33 | $75K | 133,121 |
| 2026-10-14 | JENKINS GEORGE M Director | Sale 10b5-1 | −505 | $126.55 | $64K | 132,616 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −2,004 | $128.52 | $258K | 144,960 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −1,644 | $129.23 | $212K | 143,316 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −990 | $130.48 | $129K | 142,326 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −1,035 | $131.49 | $136K | 141,291 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −579 | $132.40 | $77K | 140,712 |
| 2026-10-13 | JENKINS GEORGE M Director | Sale 10b5-1 | −922 | $133.72 | $123K | 139,790 |
| 2026-10-12 | JENKINS GEORGE M Director | Sale 10b5-1 | −5,095 | $132.62 | $676K | 155,021 |
| 2026-10-12 | JENKINS GEORGE M Director | Sale 10b5-1 | −2,458 | $133.25 | $328K | 152,563 |
Page 2 of 12 · 232 trades